INTRODUCTION
The not ion of qu a lit y of care is an important and controversial topic in today's medicine: its detractors suggest that strict quality measures and guidelines a ect "the art of medicine", while its supporters believe that it increases the delivery of evidence-based care to all patients. The process of quality improvement requires a clear definition of adequate and inadequate care markers.
is requires valid metrics and clearly established mechanisms to provide feedback in a dynamic manner that will lead to future improvement in the quality of care. The choice of quality indicators is based on existing scientific evidence or expert consensus. e chosen indicators should be readily applied and monitored to continuously evaluate and improve the quality of care.
Over the past decade, e orts to improve the quality of care in in ammatory bowel disease (IBD) patients have been made in many regions of the world.
is was mostly done by creating evidence based guidelines and centers of excellence in the eld. Increasing evidence suggests that creating such expert/excellence centers will ultimately lead to the better quality of care. ere is still a debate regarding the characteristics of a center of
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Available from: URL: http://www.jgld.ro/2014/3/20.html DOI: http://dx.doi.org/10.1543/jgld.2014.1121.233.ln1 excellence even though guidelines regarding diagnosis, treatment, managing complications and patient follow up have been released by di erent academic societies and generally been accepted by the community of caregivers.
e types of quality indicators generally used at the moment are the structural measures (indicators on the center providing care in IBD: specialized sta -gastroenterologists with interest in IBD, specialized surgeons, nurses, nutritionists, equipment, electronic medical records, a multidisciplinary approach); the process measures (indicators of the process of providing care: diagnosis, investigations, treatment, complications, and patients' interaction) and the outcome measures (indicators that assess the outcome of patients: mortality, morbidity, quality of life, patient satisfaction) [1] . e Romanian Task Force for IBD, under the auspices of the IBD 2020 initiative, decided to evaluate and to propose a comprehensive set of quality of care indicators of structure, process, and outcomes for defining and evaluating an excellence center in the eld. A er careful evaluation of the literature and panel discussions, a set of quality indicators and criteria required for an excellence center were recommended for Romanian specialized centers.
EXPERT PHYSICIANS AND GUIDELINES ADHERENCE: THE NEED FOR CENTERS OF EXCELLENCE
Evidence is growing that specialized centers are providing better care for their patients. In a Spanish survey, the degree of adherence to guidelines was high in both general and tertiary centers but the use of imaging techniques in diagnosis and follow-up signi cantly di ered. In perianal disease for example, IBD specialized gastroenterologists used magnetic resonance and surgical exploration under anesthesia more frequently than the general gastroenterologists do. Also, the IBD specialists showed signi cantly higher adherence to the guidelines in certain therapeutic areas: less use of thiopurines in refractory cases and increased use of methotrexate in corticoiddependent, azathioprine-intolerant patients and also in patients under biological treatment. Requests for infection studies and vaccinations at diagnosis or prior to treatment were also more common in the specialized centers [2] . In another study where the use of certain criteria (appropriate frequency of blood tests during the initiation/ maintenance of immunosuppressive treatment, bone protection when oral steroids were given, screening colonoscopy at 8-10 years of ulcerative colitis, annual serum urea and creatinine concentrations in patients prescribed 5-aminosalicylates, annual liver function tests, annual haematinics in patients with Crohn's disease) were assessed to monitor the quality of care, the specialist IBD clinics had better results than the non-specialist general gastroenterology clinics. Even in the specialist clinic, however, the care of a minority of patients did not ful ll certain criteria, emphasizing the need for a critical audit of outpatient management of IBD [3] .
Separating physician members of the American Gastroenterology Association (AGA) into "non-expert" and "expert" groups, based on whether a practice consisted of >50% patients with IBD, showed that experts are more comfortable using a broader array of medical therapy than non-expert physicians. Although both groups had similar concerns regarding the side-e ects of anti-TNFα therapy, expert physicians were much more likely to have managed a broad range of complications in their patient population [4] . ese studies con rm that having access to established guidelines is not enough and that we need specialized teams working together in centers with interest in IBD, in a multidisciplinary approach. is approach will permit easier access to the use of advanced diagnostic techniques and to physicians with supreme knowledge of therapeutic choices.
Creating such centers will allow easier access to our patients to modern diagnostic tools, treatment optimization and avoidance of treatment side e ects. Better colon cancer screening and expert histopathology in the eld of IBD are other advantages of such an excellence center.
MEASURES TAKEN AND REQUIRED CRITERIA
To overcome the widespread variations in the care of IBD patients, certain measures have been implemented in recent years.
In the United Kingdom, a multidisciplinary panel developed a set of IBD Standards. Although not all these standards are evidence-based, they re ect a general multidisciplinary expert consensus on what de nes quality care for patients with IBD, and include both structural standards (the setting in which care is delivered, specialists number etc.) and measures re ecting the process of care [5].
In the USA, the AGA convened a taskforce which de ned process measures in conjunction with the American Medical Association's Physician Consortium for Quality Improvement. A er public debate and comment these measures were accepted in 2012. e criteria are presented in Table I [6] . is was accomplished by starting with more than 500 potential quality indicators culled from all IBD guideline and position articles from 2006 to 2011.
A multidisciplinary panel composed of gastroenterologists representing the Crohn's Colitis Foundation of America (CCFA), the AGA and the American College of Gastroenterology (ACG), a colorectal surgeon, and patients convened for the 3 in-person moderated panels that ultimately voted on the 10 process and outcome quality indicators that composed the nal measure set for adult IBD care. e main criteria de ning an expert center according to CCFA are listed in Tables II and III . 
APPLICABILITY IN PRACTICE IN ROMANIA
Can we translate these measures into clinical practice in Romania? And will they improve our patient care in IBD?
In order to identify and implement effective quality indicators, a Romanian task force for IBD analyzed the current situation, the existing scienti c evidence and the particularities of the country. A set of measures to improve quality of care was proposed. is task force reunited some of the experts in the eld of IBD in Romania, and had the authorities (health ministry and house of insurance) and patient associations' support.
Current practice General gastroenterologists
An important number of gastroenterologists in Romania are interested in the field of IBD. Few have extensive experience; some have some experience but all wish to improve their current practice. eir educational e orts have had a substantial support from the pharmaceutical industry which permitted an increased number of meetings and scienti c symposia, courses and scholarships.
It is our belief that there is an increased interest and awareness to IBD specific problems that will lead to the improvement in the quality of care and to an increased adherence to the guidelines.
Existing "expert" centers At the moment several centers have extensive experience and expertise in IBD. is is related to their tradition but also to a constant preoccupation in the eld. ey can serve as models, as they have successfully started to provide practical courses on IBD management in the last two years with the support of the Romanian Society of Digestive Endoscopy (SRED) and Romanian Crohn's and Colitis Club (RCCC).
Although there are great differences between centers regarding the infrastructure (number of beds, emergency rooms, types of hospitalization, availability of the diagnostic tools as HD endoscopy, capsule endoscopy, echo-endoscopy, modern radiological techniques) due to a constant e ort of physicians and close collaboration between centers (state or private) a complete patient evaluation is possible in the majority of cases. e process of creating expert centers and improving quality of care is seen as a friendly and healthy competition. e ability to overcome di erences, to reach scienti c consensus and to work together for the bene t of the patients has greatly improved in the last years in the eld of gastroenterology in Romania.
One of the aspects pointed out by members of our group was the necessity of advanced endoscopy techniques in order to become an expert center, especially access to HD endoscopy and narrow band imaging. is point of view is not supported by all experts: rst of all with the current funding it will be di cult to have such equipment in all centers, also the current data is still con icting. Although the potential bene ts of newer optical and digital dye-less chromoendoscopy (DLC) techniques over traditionally used dye based chromoendoscopy (DBC) are substantial, only DBC can currently be recommended to improve dysplasia detection in long-standing IBD. In contrast, DLC has the potential to quantify disease activity and mucosal healing in IBD [8] .
The constant underfunding of the health system also poses serious barriers to any center wanting to have the newest diagnostic tools. It is our impression that even in large university centers, there is not only limited access to HD endoscopy but also a limited number of radiologists/imagists and also pathologists with experience and speci c training in IBD.
Prescription One of the main threats is the lack of predictability of the health system, its constant underfunding and reimbursement problems that ultimately pose a threat to our patients e prescription of biologic therapy is performed within a legal frame of national protocol, mostly similar to the ECCO guidelines. Although the prescription is possible for every certi ed gastroenterologist, there is a formal recommendation for the patient to have an evaluation in a university center. e patient le is also analyzed by a Commission of the Health Insurance, which has both a regulatory and clinical function: it ascertains that the protocol is respected and that the therapeutic decision is for the best interest of the patient but also within the legal protocol framework. However, data in the patient le, their accuracy and the therapeutic decision is the responsibility of the prescribing physician.
Although regarded by some as a constraint, this kind of regulatory prescription will also help with increased adherence to diagnostic and therapeutic guidelines and also will increase the quality of care o ered to the patients.
Proposed criteria
Based on international models and the current situation in Romania, simple and quanti able measures were proposed in order to obtain accreditation of the existing centers as excellence centers (Table IV) . A simpli ed version of the current international criteria adapted to the local "reality" and milieu was realized. Interestingly, our debate and set of measures are quite similar to the recent initiative by a Spanish expert group in the IBD eld, which had support from patients' associations and authorities to publish their conclusions [9] .
Accreditation and auditing
Each center will apply online and will receive a certi cate of excellence from the task force/RCCC if proven to ful ll more than 80% of the established criteria. This initiative is intended to improve the quality of care, to increase the number of participants providing "good" care and is neither an instrument to exclude centers or physicians nor a way to narrow the current practice. e auditing process, using the same measurable criteria and adherence to the measures will take place every two years. Similar to the AGA measures, the data will be published and a list of centers and physicians will be available at all times. Publishing the data will maintain the standard of quality of care due to increased e orts to remain in the "excellence league".
is will create some healthy competition and ultimately will continue to improve the quality of care.
CONCLUSIONS
Our initiative identi ed a set of quality of care indicators that will serve for evaluating and certifying excellence centers in IBD. is will help establishing clear goals and targets to di erent teams, ultimately leading to better care for the IBD patients. e strongest recommendation is the need for management of IBD in a multidisciplinary setting with respect of national/ international guidelines. Participation in the national registry is paramount. The IBD team should include specialized IBD nurses, gastroenterologists, radiologists, surgeons and endoscopists. Both outpatient and inpatient care should be o ered. An important measure should include the patients involvement in decision making and participation in their own care. Ultimately, this initiative can lead to better funding of the centers. An honest discussion between centers and a constant debate within the RCCC should assure the transparency and the scienti c weight of such an initiative, allowing negotiation with funding authorities.
We hope that all of those involved in the care of IBD patients will continue to work collaboratively in this process of improving quality of care, and that the creation of excellence centers can be a rst step in the e ort to deliver better care to our patients.
